Olof Ulf Stefan Björklund
Direktor/Vorstandsmitglied bei ProNoxis AB
Profil
Olof Ulf Stefan Björklund currently works at ProNoxis AB, as Director and Swedish Pharmaceutical Society, as Principal.
Mr. Björklund also formerly worked at OxyPharma AB, as Chief Executive Officer, Annexin Pharmaceuticals AB, as Director, Pharmacia AB, as Head-Clinical Operations, and Aprea Therapeutics AB, as Chief Operating Officer.
Mr. Björklund received his graduate degree from the University of Uppsala.
Aktive Positionen von Olof Ulf Stefan Björklund
| Unternehmen | Position | Beginn |
|---|---|---|
ProNoxis AB
 ProNoxis AB Pharmaceuticals: MajorHealth Technology ProNoxis AB develops small-molecule drugs to treat chronic inflammation. The company was founded in 2009 and is headquartered in Lund, Sweden. | Direktor/Vorstandsmitglied | - |
| Swedish Pharmaceutical Society | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Olof Ulf Stefan Björklund
| Unternehmen | Position | Ende |
|---|---|---|
| ANNEXIN PHARMACEUTICALS AB | Direktor/Vorstandsmitglied | - |
| OxyPharma AB | Präsident | - |
| Pharmacia AB | Corporate Officer/Principal | - |
Aprea Therapeutics AB
 Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Vorstandsvorsitzender | 20.10.2014 |
Ausbildung von Olof Ulf Stefan Björklund
| University of Uppsala | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ANNEXIN PHARMACEUTICALS AB | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Aprea Therapeutics AB
Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Health Technology |
ProNoxis AB
ProNoxis AB Pharmaceuticals: MajorHealth Technology ProNoxis AB develops small-molecule drugs to treat chronic inflammation. The company was founded in 2009 and is headquartered in Lund, Sweden. | Health Technology |
| OxyPharma AB | |
| Swedish Pharmaceutical Society | |
| Pharmacia AB | Health Technology |
